Figure 1. CDK4/6 inhibitor therapy for premenopausal patients with advanced HR+/HER2–
breast cancer: Effect on overall survival during MONALEESA-7 study.#7
Fig1_STEaM
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.